129 related articles for article (PubMed ID: 32664334)
1. Role of Tobramycin in the Induction and Maintenance of Viable but Non-Culturable
Mangiaterra G; Cedraro N; Vaiasicca S; Citterio B; Galeazzi R; Laudadio E; Mobbili G; Minnelli C; Bizzaro D; Biavasco F
Antibiotics (Basel); 2020 Jul; 9(7):. PubMed ID: 32664334
[TBL] [Abstract][Full Text] [Related]
2. Contribution of Drugs Interfering with Protein and Cell Wall Synthesis to the Persistence of
Mangiaterra G; Carotti E; Vaiasicca S; Cedraro N; Citterio B; La Teana A; Biavasco F
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562782
[TBL] [Abstract][Full Text] [Related]
3. Involvement of Acquired Tobramycin Resistance in the Shift to the Viable but Non-Culturable State in
Mangiaterra G; Cedraro N; Vaiasicca S; Citterio B; Frangipani E; Biavasco F; Vignaroli C
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511375
[TBL] [Abstract][Full Text] [Related]
4. An Antipersister Strategy for Treatment of Chronic Pseudomonas aeruginosa Infections.
Koeva M; Gutu AD; Hebert W; Wager JD; Yonker LM; O'Toole GA; Ausubel FM; Moskowitz SM; Joseph-McCarthy D
Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28923873
[TBL] [Abstract][Full Text] [Related]
5. Use of Calgary and Microfluidic BioFlux Systems To Test the Activity of Fosfomycin and Tobramycin Alone and in Combination against Cystic Fibrosis Pseudomonas aeruginosa Biofilms.
Díez-Aguilar M; Morosini MI; Köksal E; Oliver A; Ekkelenkamp M; Cantón R
Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29084746
[No Abstract] [Full Text] [Related]
6. Tobramycin-Treated Pseudomonas aeruginosa PA14 Enhances Streptococcus constellatus 7155 Biofilm Formation in a Cystic Fibrosis Model System.
Price KE; Naimie AA; Griffin EF; Bay C; O'Toole GA
J Bacteriol; 2016 Jan; 198(2):237-47. PubMed ID: 26483523
[TBL] [Abstract][Full Text] [Related]
7. In vitro approach to study the synergistic effects of tobramycin and clarithromycin against Pseudomonas aeruginosa biofilms using prokaryotic or eukaryotic culture media.
Thellin O; Zorzi W; Jolois O; Elmoualij B; Duysens G; Cahay B; Streel B; Charif M; Bastin R; Heinen E; Quatresooz P
Int J Antimicrob Agents; 2015 Jul; 46(1):33-8. PubMed ID: 25963337
[TBL] [Abstract][Full Text] [Related]
8. Detection of viable but non-culturable Pseudomonas aeruginosa in cystic fibrosis by qPCR: a validation study.
Mangiaterra G; Amiri M; Di Cesare A; Pasquaroli S; Manso E; Cirilli N; Citterio B; Vignaroli C; Biavasco F
BMC Infect Dis; 2018 Dec; 18(1):701. PubMed ID: 30587160
[TBL] [Abstract][Full Text] [Related]
9. Sequential Treatment of Biofilms with Aztreonam and Tobramycin Is a Novel Strategy for Combating Pseudomonas aeruginosa Chronic Respiratory Infections.
Rojo-Molinero E; Macià MD; Rubio R; Moyà B; Cabot G; López-Causapé C; Pérez JL; Cantón R; Oliver A
Antimicrob Agents Chemother; 2016 May; 60(5):2912-22. PubMed ID: 26926631
[TBL] [Abstract][Full Text] [Related]
10. Role of viable but non culturable cells in patients with cystic fibrosis in the era of highly effective modulator therapy.
Cirilli N; Schiavoni V; Tagliabracci V; Gesuita R; Tiano L; Fabrizzi B; D'Antuono A; Peruzzi A; Cedraro N; Carle F; Moretti M; Ferrante L; Vignaroli C; Biavasco F; Mangiaterra G
J Cyst Fibros; 2024 Feb; ():. PubMed ID: 38423895
[TBL] [Abstract][Full Text] [Related]
11. Influence of Excipients on the Antimicrobial Activity of Tobramycin Against Pseudomonas aeruginosa Biofilms.
Bahamondez-Canas T; Smyth HDC
Pharm Res; 2018 Jan; 35(1):10. PubMed ID: 29294187
[TBL] [Abstract][Full Text] [Related]
12. [Effects of Imipenem, Tobramycin and Curcumin on Biofilm Formation of Pseudomonas aeruginosa Strains].
Karaman M; Fırıncı F; Arıkan Ayyıldız Z; Bahar IH
Mikrobiyol Bul; 2013 Jan; 47(1):192-4. PubMed ID: 23390919
[TBL] [Abstract][Full Text] [Related]
13. Asiatic acid and corosolic acid enhance the susceptibility of Pseudomonas aeruginosa biofilms to tobramycin.
Garo E; Eldridge GR; Goering MG; DeLancey Pulcini E; Hamilton MA; Costerton JW; James GA
Antimicrob Agents Chemother; 2007 May; 51(5):1813-7. PubMed ID: 17353241
[TBL] [Abstract][Full Text] [Related]
14. Effects of iron depletion on antimicrobial activities against planktonic and biofilm Pseudomonas aeruginosa.
Cai Y; Yu XH; Wang R; An MM; Liang BB
J Pharm Pharmacol; 2009 Sep; 61(9):1257-62. PubMed ID: 19703377
[TBL] [Abstract][Full Text] [Related]
15. Mannitol Does Not Enhance Tobramycin Killing of Pseudomonas aeruginosa in a Cystic Fibrosis Model System of Biofilm Formation.
Price KE; Orazi G; Ruoff KL; Hebert WP; O'Toole GA; Mastoridis P
PLoS One; 2015; 10(10):e0141192. PubMed ID: 26506004
[TBL] [Abstract][Full Text] [Related]
16. Antibiotic pressure can induce the viable but non-culturable state in Staphylococcus aureus growing in biofilms.
Pasquaroli S; Zandri G; Vignaroli C; Vuotto C; Donelli G; Biavasco F
J Antimicrob Chemother; 2013 Aug; 68(8):1812-7. PubMed ID: 23515246
[TBL] [Abstract][Full Text] [Related]
17. Pseudomonas aeruginosa biofilms are more susceptible to ciprofloxacin than to tobramycin.
Preston CA; Khoury AE; Reid G; Bruce AW; Costerton JW
Int J Antimicrob Agents; 1996 Oct; 7(4):251-6. PubMed ID: 18611764
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of long-term co-administration of tobramycin and clarithromycin in a mature biofilm model of cystic fibrosis clinical isolates of Pseudomonas aeruginosa.
Tré-Hardy M; Traore H; El Manssouri N; Vanderbist F; Vaneechoutte M; Devleeschouwer MJ
Int J Antimicrob Agents; 2009 Oct; 34(4):370-4. PubMed ID: 19505804
[TBL] [Abstract][Full Text] [Related]
19. Bismuth-thiol incorporation enhances biological activities of liposomal tobramycin against bacterial biofilm and quorum sensing molecules production by Pseudomonas aeruginosa.
Halwani M; Hebert S; Suntres ZE; Lafrenie RM; Azghani AO; Omri A
Int J Pharm; 2009 May; 373(1-2):141-6. PubMed ID: 19429299
[TBL] [Abstract][Full Text] [Related]
20. Role of daptomycin in the induction and persistence of the viable but non-culturable state of Staphylococcus aureus biofilms.
Pasquaroli S; Citterio B; Cesare AD; Amiri M; Manti A; Vuotto C; Biavasco F
Pathogens; 2014 Sep; 3(3):759-68. PubMed ID: 25438023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
